MedReview appoints Zachary Molloie as Chief Legal and Compliance Officer. Science · JUL 7, 2026 PR Newswire NEW YORK and NEWPORT BEACH, Calif., July 7, 2026 /PRNewswire/ - MedReview, a leading provider of physician-approved prepay and postpay payment integrity... NEW YORK and NEWPORT BEACH, Calif., July 7, 2026 /PRNewswire/ - MedReview, a leading provider of physician-approved prepay and postpay payment integrity solutions, welcomes Zachary Molloie as Chief Legal and Compliance Officer. MedReview welcomes Zachary Molloie as Chief Legal and Compliance Officer. Zachary brings over a decade of experience building and leading legal, compliance, and operational functions within rapidly growing organizations. His strategic approach supports an organization's business goals, from achieving significant cost reductions to securing patents for innovative AI-enabled technologies and beyond. Prior to joining MedReview, Zachary served as General Counsel and Chief People Officer at Peachy, a fast-growing preventative aesthetics company, where he built the company's legal and people functions from the ground up. Zachary received his J.D. from George Mason University School of Law and is admitted to the bar in Maryland and New York. In his new role, Zachary oversees all legal activities, including contracts, employment, regulatory compliance, and litigation. He also serves as MedReview's HIPAA Privacy Officer and chairs the Compliance Committee, ensuring the company's operations align with applicable healthcare laws and regulations, including Medicaid and Medicare requirements. "We are pleased to add Zachary's expertise navigating complex regulatory landscapes - including the evolving legal challenges and opportunities in the healthcare technology space - to our team," says Spencer Young, Chief Executive Officer of MedReview. "His guidance will help fuel our innovation and growth while ensuring we remain a trusted partner to our customers." About MedReview MedReview is a leading authority in the payment integrity space with more than 50 years of experience. Our physician-led solutions combine clinical expertise with proprietary technology to ensure healthcare claims accurately represent the care provided. To date, MedReview's independent audits and clinical validation processes have delivered more than $3 billion in savings to clients, while helping take cost out of the healthcare system. Visit www.medreview.us to learn more. SOURCE MedReview Published by News Desk · WeeklyReviewer The WeeklyReviewer news desk monitors breaking developments around the clock - sourcing, verifying, and publishing real-time industry news across business, technology, politics, science, sports, and world affairs. Every story that comes through the Live Wire is reviewed for accuracy before publication, keeping our readers ahead of the curve without the noise.

Peachy, a multi-unit beauty services brand specialising in neuromodulator injections, has received a minority investment from Stride Consumer Partners. The company, founded in 2019 by Dr Carolyn Treasure and Eric Zhang, operates 15 studios across six US cities including New York, Chicago and Washington DC. Peachy grew revenue by over 60% last year whilst expanding from 12 to 15 locations. The company employs board-certified nurse practitioners and uses a transparent flat-fee pricing model for preventative skincare treatments. The growth capital will support location expansion, brand development and talent recruitment. This marks Peachy's first private equity partnership; existing investors include BrandProject, Brand Foundry Ventures and Great Oaks Venture Capital. North Point and Lowenstein Sandler advised Peachy on the transaction.